MedPath

Improving care for diabetic patients on dialysis: can using a new device to identify risk periods of ‘high’ and ‘low’ blood sugars in both hospital and home dialysis patients

Not Applicable
Completed
Conditions
Renal failure
Urological and Genital Diseases
Registration Number
ISRCTN58101486
Lead Sponsor
Portsmouth Hospitals NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
89
Inclusion Criteria

1. Male or Female aged 18 years or above
2. Diagnosis of Diabetes Mellitus requiring insulin therapy
3. On Renal Replacement Therapy for a minimum of 3 months
4. Have downloadable SGBM devise already in use

Exclusion Criteria

1. Acute prescription (within 2 weeks) of medication that may increase or decrease serum glucose
2. Planned change of renal replacement modality during study period
3. Co-enrolment in other studies that provided therapies or interventions that may affect glycaemia control
4. Unable to provide informed consent

Added 29/12/2016:
5. Planned x-ray, computed tomography (CT) scan, magnetic resonance imaging (MRI) or high-frequency electrical heat (diathermy) treatment during the study period

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Primary outcome measure as of 29/12/2016:<br> Ambulatory glucose profile as generated by 14 days of interstitial glucose monitoring.<br><br> Original primary outcome measure:<br> Overall glycaemic variability is determined using interstitial glucose measurements collected by a continuous glucose monitor over a 14 day period.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath